MDT
NYSE · Health Care
Medtronic Plc
$90.58
-0.18 (-0.20%)
Financial Highlights (FY 2026)
Revenue
35.42B
Net Income
4.67B
Gross Margin
65.3%
Profit Margin
13.2%
Rev Growth
+5.2%
D/E Ratio
0.57
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 65.3% | 65.3% | 65.6% | 65.6% |
| Operating Margin | 17.8% | 16.0% | 18.7% | 15.7% |
| Profit Margin | 13.2% | 12.5% | 13.2% | 12.8% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 35.42B | 33.66B | 38.01B | 39.84B |
| Gross Profit | 23.13B | 21.98B | 24.94B | 26.14B |
| Operating Income | 6.30B | 5.39B | 7.11B | 6.27B |
| Net Income | 4.67B | 4.00B | 5.01B | 5.11B |
| Gross Margin | 65.3% | 65.3% | 65.6% | 65.6% |
| Operating Margin | 17.8% | 16.0% | 18.7% | 15.7% |
| Profit Margin | 13.2% | 12.5% | 13.2% | 12.8% |
| Rev Growth | +5.2% | +5.2% | +7.6% | +8.9% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 19.74B | 19.74B | 46.06B | 47.08B |
| Total Equity | 34.93B | 34.93B | 64.44B | 73.11B |
| D/E Ratio | 0.57 | 0.57 | 0.71 | 0.64 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 8.02B | 7.25B | 10.33B | 9.57B |
| Free Cash Flow | — | — | 5.93B | 5.01B |